Sincalide

規格

25126-32-3CAS番号

246-639-0EC番号

(3S)-3-amino-4-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-4-methylsIUPAC名

C49H62N10O16S3化学式

1143.3 g/mol分子量

Sincalide; 25126-32-3; CCK-8; Kinevac; Sincalida; CCK-8S; Sincalidum; Syncalide; SQ 19844; cholecystokinin C-terminal octapeptide; DTXSID7048617; CCK C-terminal octapeptide; SQ-19844; M03GIQ7Z6P; H-Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2; Caerulein, 1-de(5-oxo-L-proline)-2-de-L-glutamine-5-L-methionine-; Cholecystokinin octapeptide; DTXCID4028543; L-alpha-Aspartyl-O-sulfo-L-tyrosyl-L-methionylglycyl-L-tryptophyl-L-methionyl-L-alpha-aspartyl-L-phenylalaninamide; L-Aspartyl-L-tyrosyl-L-methionylglycyl-L-tryptophyl-L-methionyl-L-aspartylphenyl-L-alaninamide hydrogen sulfate (ester); 1-De(5-oxo-L-proline)-2-de-L-glutamine-5-L-methioninecaerulein; (3S)-3-amino-4-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-1-oxo-3-(4-sulfooxyphenyl)propan-2-yl]amino]-4-oxobutanoic acid; CCK-OP; OP-CCK; (3S)-3-(((2S)-2-(((2S)-2-((2-(((2S)-2-(((2S)-2-(((2S)-2-amino-4-hydroxy-4-oxobutanoyl)amino)-3-(4-sulfooxyphenyl)propanoyl)amino)-4-methylsulfanylbutanoyl)amino)acetyl)amino)-3-(1H-indol-3-yl)propanoyl)amino)-4-methylsulfanylbutanoyl)amino)-4-(((2S)-1-amino-1-oxo-3-phenylpropan-2-yl)amino)-4-oxobutanoic acid; (3S)-3-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-hydroxy-4-oxobutanoyl]amino]-3-(4-sulfooxyphenyl)propanoyl]amino]-4-methylsulfanylbutanoyl]amino]acetyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid; (3S)-3-amino-4-(((2S)-1-(((2S)-1-((2-(((2S)-1-(((2S)-1-(((2S)-1-(((2S)-1-amino-1-oxo-3-phenylpropan-2-yl)amino)-3-carboxy-1-oxopropan-2-yl)amino)-4-methylsulfanyl-1-oxobutan-2-yl)amino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)amino)-2-oxoethyl)amino)-4-methylsulfanyl-1-oxobutan-2-yl)amino)-1-oxo-3-(4-sulfooxyphenyl)propan-2-yl)amino)-4-oxobutanoic acid; SQ19844; SQ19,844; RefChem:57816; SQ 19,844; Cholecystokinin Pancreozymin C Terminal Octapeptide; Cholecystokinin Pancreozymin C-Terminal Octapeptide; DTXSID7040443; V04CC03; 246-639-0; L-Aspartyl-L-tyrosyl-L-methionylglycyl-L-tryptophyl-L-methionyl-L-aspartylphenyl-L-alaninamide Hydrogen Sulfate(ester); 3-10-Caerulein, 5-L-methionine-; MFCD00079849; CHEMBL1121; cholecystokinin 8; C49H62N10O16S3; CAS-25126-32-3; Human CCK-8; CCK-8 (sulphated); Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2; Sincalidum [INN-Latin]; Sincalida [INN-Spanish]; Cholecystokinin-pancreozymin; UNII-M03GIQ7Z6P; Sincalide [USAN:USP:INN:BAN]; NCGC00183278-01; NCGC00183363-01; EINECS 246-639-0; Kinevac (TN); SINCALIDE [INN]; SINCALIDE [MI]; CCK Octapeptide sulfated; Sincalide (USAN/INN); SINCALIDE [USAN]; SINCALIDE [VANDF]; SINCALIDE [MART.]; SINCALIDE [WHO-DD]; GTPL864; SCHEMBL122365; CCK-8(SO3); orb1296714; SINCALIDE [ORANGE BOOK]; SCHEMBL29350919; SINCALIDE [USP IMPURITY]; BDBM21147; EX-A8006C; CHEBI:135946; [125I]CCK-8; HY-P0093; Tox21_112955; Tox21_113481; EBC-27533; TP1197; AKOS016340423; CS-5963; DB09142; FS41124; HS-2026; NCGC00167273-01; (3S)-3-[(2S)-2-[(2S)-2-{2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-[4-(sulfooxy)phenyl]propanamido]-4-(methylsulfanyl)butanamido]acetamido}-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-{[(1S)-1-carbamoyl-2-phenylethyl]carbamoyl}propanoic acid; (3S,6S,9S,15S,18S,21S)-9-((1H-indol-3-yl)methyl)-21-amino-3-(((S)-1-amino-1-oxo-3-phenylpropan-2-yl)carbamoyl)-6,15-bis(2-(methylthio)ethyl)-5,8,11,14,17,20-hexaoxo-18-(4-(sulfooxy)benzyl)-4,7,10,13,16,19-hexaazatricosanedioic acid; AC-38388; Cholecystokinin, CCK Octapeptide (26-33); NS00050642; D05845; E78048; Asp26-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-PheNH2; CHOLECYSTOKININ C-TERMINAL OCTAPEPTIDE [MI]; EN300-19650945; Q7521885; (3S)-3-[(2S)-2-[(2S)-2-{2-[(2S)-2-[(2S)-2-[(3S)-3-amino-3-formamidopropanoic acid]-3-[4-(sulfooxy)phenyl]propanamido]-4-(methylsulfanyl)butanamido]acetamido}-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-{[(1S)-1-carbamoyl-2-phenylethyl]carbamoyl}propanoic acid; (3S)-3-amino-4-[[(1S)-2-[[(1S)-1-[[2-[[(1S)-2-[[(1S)-1-[[(1S)-2-[[(1S)-2-amino-1-benzyl-2-oxo-ethyl]amino]-1-(carboxymethyl)-2-oxo-ethyl]carbamoyl]-3-methylsulfanyl-propyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-2-oxo-ethyl]carbamoyl]-3-methylsulfanyl-propyl]amino]-2-oxo-1-[(4-sulfooxyphenyl)methyl]ethyl]amino]-4-oxo-butanoic acid; (3S,6S,9S,15S,18S,21S)-9-((1H-indol-3-yl)methyl)-21-amino-3-(((S)-1-amino-1-oxo-3-phenylpropan-2-yl)carbamoyl)-6,15-bis(2-(methylthio)ethyl)-5,8,11,14,17,20-hexaoxo-18-(4-(sulfooxy)benzyl)-4,7,10,13,16,19-hexaazatricosane-1,23-dioic acid; L-.ALPHA.-ASPARTYL-O-SULFO-L-TYROSYL-L-METHIONYLGLYCYL-L-TRYPTOPHYL-L-METHIONYL-L-.ALPHA.-ASPARTYL-L-PHENYLALANINAMIDE別名